celiprolol has been researched along with Cardiac Remodeling, Ventricular in 4 studies
Celiprolol: A cardioselective beta-1 adrenergic antagonist that has intrinsic sympathomimetic activity. It is used in the management of ANGINA PECTORIS and HYPERTENSION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Both celiprolol and candesartan showed cardioprotective effects in this heart failure model." | 7.73 | Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. ( Hayashi, T; Kitaura, Y; Matsumura, Y; Mori, T; Ohkita, M; Okuda, N; Shimomura, H; Sohmiya, K; Yoshikawa, J; Yoshiyama, M, 2005) |
| "Both celiprolol and candesartan showed cardioprotective effects in this heart failure model." | 3.73 | Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure. ( Hayashi, T; Kitaura, Y; Matsumura, Y; Mori, T; Ohkita, M; Okuda, N; Shimomura, H; Sohmiya, K; Yoshikawa, J; Yoshiyama, M, 2005) |
| " Celiprolol (DOCA-CEL, n = 9, 10 mg/kg per day, subdepressor dose) or a vehicle (DOCA-V, n = 9) were given after induction of DOCA-salt hypertension for 5 weeks, and age-matched sham-operated rats (ShC, n = 9) served as a control group." | 3.71 | Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats. ( Kobayashi, N; Matsuoka, H; Mori, Y; Nakano, S; Shirataki, H; Tsubokou, Y, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nishioka, S | 1 |
| Yoshioka, T | 1 |
| Nomura, A | 1 |
| Kato, R | 1 |
| Miyamura, M | 1 |
| Okada, Y | 1 |
| Ishizaka, N | 1 |
| Matsumura, Y | 2 |
| Hayashi, T | 2 |
| Tsubokou, Y | 2 |
| Kobayashi, N | 2 |
| Mita, S | 1 |
| Yoshida, K | 1 |
| Matsuoka, H | 2 |
| Mori, T | 1 |
| Sohmiya, K | 1 |
| Okuda, N | 1 |
| Shimomura, H | 1 |
| Ohkita, M | 1 |
| Yoshiyama, M | 1 |
| Yoshikawa, J | 1 |
| Kitaura, Y | 1 |
| Mori, Y | 1 |
| Nakano, S | 1 |
| Shirataki, H | 1 |
4 other studies available for celiprolol and Cardiac Remodeling, Ventricular
| Article | Year |
|---|---|
Celiprolol reduces oxidative stress and attenuates left ventricular remodeling induced by hypoxic stress in mice.
Topics: Adrenergic beta-1 Receptor Antagonists; Animals; Blood Pressure; Celiprolol; Heart; Heart Rate; Hypo | 2013 |
Celiprolol inhibits mitogen-activated protein kinase and endothelin-1 and transforming growth factor-beta(1) gene in rats.
Topics: Adrenergic beta-Antagonists; Animals; Blotting, Western; Body Weight; Celiprolol; Desoxycorticostero | 2002 |
Mechanisms of combined treatment with celiprolol and candesartan for ventricular remodeling in experimental heart failure.
Topics: Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Celiprolol; Disease Models, An | 2005 |
Celiprolol stimulates endothelial nitric oxide synthase expression and improves myocardial remodeling in deoxycorticosterone acetate-salt hypertensive rats.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Blotting, Western; Celiprolol; Collagen; Desox | 2001 |